Our study elucidated the important role of DAGLA in HCC progression via 2-AG-induced YAP signalling and EMT, which prompted us to hypothesise that DAGLA may regulate the sensitivity of HCC cells to multikinase inhibitor treatment. Here, DAGLA is linked to hepatocellular carcinoma.